Protean BioDiagnostics
Cart 0
Full Test Menu Cancer Screening Tests Test Ordering Information Test Requisition Forms
Cancer Test Menu Protean MAPS® Genetic Testing: Risk MAPS™
Research Services Collaborative Research Opportunities Research Publications
Cancer Consultations Cancer Test Information Risk MAPS™ Hereditary Testing
About Us Hours The Team Pathologists Careers Contact
Blog Events Press Podcast
Cart 0
Test Menu Full Test Menu Cancer Screening Tests Test Ordering Information Test Requisition Forms Physicians + Hospitals Cancer Test Menu Protean MAPS® Genetic Testing: Risk MAPS™ CRO Research Services Collaborative Research Opportunities Research Publications Patients Cancer Consultations Cancer Test Information Risk MAPS™ Hereditary Testing About About Us Hours The Team Pathologists Careers Contact News Blog Events Press Podcast
Protean BioDiagnostics
Biocept, Protean BioDiagnostics Team up to Study EGFR Assay in Lung Cancer

Staff Reporter at Precision Oncology News
February 23, 2021

Link to Original Article

Anthony MaglioccoFebruary 23, 2021Precision Oncology News
Facebook0 Twitter LinkedIn0
Previous

Biocept Teams Up with Protean BioDiagnostics to Study Target Selector in Determining EGFR Mutations in Tumor Samples

Anthony MaglioccoFebruary 23, 2021Andrew Kessel, Proactive Investors
Next

Biocept and Protean BioDiagnostics Establish Research Collaboration to Demonstrate Advantages of Biocept’s Target Selector™ Assay Kit for Non-Small Cell Lung Cancer Patients

Anthony MaglioccoFebruary 23, 2021Business Wire
 
 

Physicians and Hospitals | Patients | Research Partners
Careers | Blog | Press | Contact | Research Publications

Notice of Privacy Practices